Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

BackgroundAlthough considerable effort has been put into decoding of the osteosarcoma genome, very little is known about germline mutations that underlie this primary malignant tumour of bone.Methods and resultsWe followed here a coincidental finding in a multiple endocrine neoplasia family in which a 32-year-old patient carrying a germline pathogenic RET mutation developed an osteosarcoma 2 years after the resection of a medullary thyroid carcinoma. Sequencing analysis of additional 336 patients with osteosarcoma led to the identification of germline activating mutations in the RET proto-oncogene in three cases and somatic amplifications of the gene locus in five matched tumours (4%, n=5/124 tumours). Functional analysis of the pathogenic variants together with an integrative analysis of osteosarcoma genomes confirmed that the mutant RET proteins couple functional kinase activity to dysfunctional ligand binding. RET mutations further co-operated with alterations in TP53 and RB1, suggesting that osteosarcoma pathogenesis bears reminiscence to the stepwise model of medullary thyroid carcinoma.ConclusionsAfter Li-Fraumeni-predisposing mutations in TP53, RET becomes the second most mutated cancer-predisposing gene in the germline of patients with osteosarcoma. Hence, early identification of RET mutation carriers can help to identify at-risk family members and carry out preventive measures.

Original publication

DOI

10.1136/jmedgenet-2019-106734

Type

Journal article

Journal

Journal of medical genetics

Publication Date

01/2021

Volume

58

Pages

20 - 24

Addresses

Institute for Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland michal.kovac@usb.ch.

Keywords

Humans, Osteosarcoma, Carcinoma, Neuroendocrine, Thyroid Neoplasms, Genetic Predisposition to Disease, Ubiquitin-Protein Ligases, Pediatrics, Germ-Line Mutation, Adult, Aged, Female, Male, Tumor Suppressor Protein p53, Proto-Oncogene Proteins c-ret, Retinoblastoma Binding Proteins, Proto-Oncogene Mas